Shockwave Medical Inc (DELISTED) (SWAV:DL)
334.75
-0.08
(-0.02%)
USD |
NASDAQ |
May 30, 16:00
Shockwave Medical Profit Margin (Quarterly): 25.29% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 25.29% |
December 31, 2023 | 21.83% |
September 30, 2023 | 18.81% |
June 30, 2023 | 16.02% |
March 31, 2023 | 24.29% |
December 31, 2022 | 97.84% |
September 30, 2022 | 26.65% |
June 30, 2022 | 21.17% |
March 31, 2022 | 15.51% |
December 31, 2021 | 15.37% |
September 30, 2021 | 2.99% |
June 30, 2021 | -0.76% |
March 31, 2021 | -73.98% |
Date | Value |
---|---|
December 31, 2020 | -69.88% |
September 30, 2020 | -66.01% |
June 30, 2020 | -176.1% |
March 31, 2020 | -123.5% |
December 31, 2019 | -103.0% |
September 30, 2019 | -114.3% |
June 30, 2019 | -106.0% |
March 31, 2019 | -176.1% |
December 31, 2018 | -221.7% |
September 30, 2018 | -282.7% |
June 30, 2018 | -443.5% |
March 31, 2018 | -725.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-176.1%
Minimum
Jun 2020
97.84%
Maximum
Dec 2022
-23.26%
Average
15.37%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
Boston Scientific Corp | 12.76% |
Masimo Corp | 3.84% |
Tactile Systems Technology Inc | -3.62% |
RxSight Inc | -30.83% |
Perspective Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 25.47% |
Return on Assets | 13.07% |
Return on Invested Capital | 14.77% |
Gross Profit Margin (Quarterly) | 87.11% |
Operating Margin (Quarterly) | 19.38% |
Return on Net Operating Assets | 37.88% |